UBS Securities LLC and UBS Financial Services, Inc. | UBS | financial services | investor protection violation | 2008 | MULTI-AG | $11,150,000,000 |
Credit Suisse | UBS | financial services | toxic securities abuses | 2017 | DOJ_CIVIL | $5,280,000,000 |
Credit Suisse AG | UBS | financial services | tax violations | 2014 | DOJ_TAX | $1,800,000,000 |
UBS AG | UBS | financial services | toxic securities abuses | 2023 | DOJ_CIVIL | $1,435,000,000 |
Glencore International A.G. | Glencore | financial services | price-fixing or anti-competitive practices | 2022 | CFTC | $1,186,000,000 |
Glencore International A.G. and Glencore Ltd. | Glencore | financial services | Foreign Corrupt Practices Act | 2022 | DOJ_CRIMINAL | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,185,000,000 |
Transocean | Transocean | oilfield services and supplies | environmental violation | 2013 | EPA | $1,000,000,000 |
Credit Suisse | UBS | financial services | toxic securities abuses | 2014 | FHFA | $885,000,000 |
UBS Americas Inc. | UBS | financial services | toxic securities abuses | 2013 | FHFA | $885,000,000 |
UBS AG | UBS | financial services | tax violations | 2009 | DOJ_TAX | $780,000,000 |
Lafarge S.A. | Holcim Group | building materials | payment to designated terrorist organization | 2022 | USAO | $777,780,000 |
Credit Suisse AG | UBS | financial services | tax violations | 2014 | NY-DFS | $715,000,000 |
UBS AG | UBS | financial services | price-fixing or anti-competitive practices | 2012 | CFTC | $700,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $642,000,000 |
Bank Julius Baer & Co. Ltd. | Julius Baer Group | financial services | tax violations | 2016 | DOJ_TAX | $547,000,000 |
UBS Securities Japan Co. Ltd. | UBS | financial services | price-fixing or anti-competitive practices | 2012 | DOJ_ANTITRUST | $500,000,000 |
Credit Suisse Securities (USA) LLC et al. | UBS | financial services | investor protection violation | 2022 | NJ-AG | $495,000,000 |
UBS | UBS | financial services | toxic securities abuses | 2017 | NCUA | $445,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $422,500,000 |
Transocean Deepwater Inc. | Transocean | oilfield services and supplies | environmental violation | 2013 | EPA | $400,000,000 |
Novartis Pharmaceuticals | Novartis | pharmaceuticals | kickbacks and bribery | 2015 | USAO | $390,000,000 |
UBS AG | UBS | financial services | banking violation | 2015 | FED | $342,000,000 |
ABB Ltd. | ABB Ltd. | utilities and power generation | Foreign Corrupt Practices Act | 2022 | DOJ_CRIMINAL | $315,000,000 |
UBS AG | UBS | financial services | price-fixing or anti-competitive practices | 2014 | CFTC | $290,000,000 |
UBS Group AG | UBS | financial services | banking violation | 2023 | FED | $268,500,000 |
Credit Suisse AG | UBS | financial services | economic sanction violation | 2009 | DOJ_CRIMINAL | $268,000,000 |
Credit Suisse AG | UBS | financial services | economic sanction violation | 2009 | NY-MANDA | $268,000,000 |
Novartis Hellas S.A.C.I. et al. | Novartis | pharmaceuticals | Foreign Corrupt Practices Act | 2020 | DOJ_CRIMINAL | $233,000,000 |
UBS Securities LLC | UBS | financial services | toxic securities abuses | 2018 | NY-AG | $230,000,000 |
Transocean Ltd. | Transocean | oilfield services and supplies | environmental violation | 2017 | private lawsuit-federal | $211,750,000 |
UBS AG | UBS | financial services | price-fixing or anti-competitive practices | 2015 | DOJ_CRIMINAL | $203,000,000 |
UBS AG | UBS | financial services | tax violations | 2009 | SEC | $200,000,000 |
Credit Suisse First Boston LLC | UBS | financial services | investor protection violation | 2003 | SEC | $200,000,000 |
Credit Suisse First Boston Corp. | UBS | financial services | investor protection violation | 2002 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $200,000,000 |
Credit Suisse Group AG | UBS | financial services | investor protection violation | 2014 | SEC | $196,000,000 |
Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $195,000,000 |
Union Bancaire Privee | Union Bancaire Privee | financial services | tax violations | 2016 | DOJ_TAX | $187,000,000 |
Sandoz Inc. | Sandoz Group | pharmaceuticals | False Claims Act and related | 2021 | DOJ_CIVIL | $185,000,000 |
Credit Suisse Group AG | UBS | financial services | fraud | 2021 | DOJ_CRIMINAL | $175,500,000 |
Lafarge North America Inc. | Holcim Group | building materials | environmental violation | 2010 | EPA | $175,000,000 |
Novartis Corporation | Novartis | pharmaceuticals | employment discrimination | 2010 | private lawsuit-federal | $175,000,000 |
Zurich American Insurance Company | Zurich Insurance | financial services | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $171,700,000 |
UBS AG | UBS | financial services | price-fixing or anti-competitive practices | 2011 | DOJ_ANTITRUST | $160,000,000 |
Credit Suisse GroupAG | UBS | financial services | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $155,333,333 |
UBS Group AG | UBS | financial services | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $155,333,333 |
UBS Securities LLC and UBS Financial Services Inc. | UBS | financial services | investor protection violation | 2008 | MULTI-FIN | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $150,000,000 |
Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $150,000,000 |
Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $142,494,000 |
UBS AG | UBS | financial services | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $141,075,000 |
Credit Suisse AG | UBS | financial services | price-fixing or anti-competitive practices | 2017 | NY-DFS | $135,000,000 |
Vitol Inc. | Vitol | financial services | Foreign Corrupt Practices Act | 2020 | DOJ_CRIMINAL | $135,000,000 |
Hoffmann-La Roche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $130,000,000 |
Novartis AG | Novartis | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $126,850,000 |
Credit Suisse Securities (USA) LLC | UBS | financial services | investor protection violation | 2022 | SEC | $125,000,000 |
UBS Securities LLC and UBS Financial Services Inc. | UBS | financial services | investor protection violation | 2022 | SEC | $125,000,000 |
Credit Suisse Securities (USA) | UBS | financial services | toxic securities abuses | 2012 | SEC | $120,000,000 |
UBS | UBS | financial services | investor protection violation | 2010 | MI-AG | $117,000,000 |
Novartis AG | Novartis | pharmaceuticals | Foreign Corrupt Practices Act | 2020 | SEC | $112,800,000 |
Credit Suisse | UBS | financial services | consumer protection violation | 2016 | private lawsuit-federal | $110,000,000 |
Novartis Pharmaceuticals Corp. | Novartis | pharmaceuticals | kickbacks and bribery | 2020 | MULTI-AG | $103,000,000 |
Credit Suisse AG | UBS | financial services | banking violation | 2014 | FED | $100,000,000 |
UBS AG | UBS | financial services | economic sanction violation | 2004 | FED | $100,000,000 |
Credit Suisse First Boston Corporation | UBS | financial services | investor protection violation | 2002 | SEC | $100,000,000 |
Novartis | Novartis | pharmaceuticals | wage and hour violation | 2012 | private lawsuit-federal | $99,000,000 |
Credit Suisse Group AG | UBS | financial services | Foreign Corrupt Practices Act | 2021 | SEC | $99,000,000 |
Vitol Inc. | Vitol | financial services | fraud | 2020 | CFTC | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $95,700,000 |
UBS AG | UBS | financial services | price-fixing or anti-competitive practices | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $90,800,000 |
Credit Suisse AG | UBS | financial services | accounting fraud or deficiencies | 2016 | SEC | $90,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $88,258,694 |
Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $85,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | kickbacks and bribery | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $83,129,754 |
UBS Warburg LLC | UBS | financial services | investor protection violation | 2003 | SEC | $80,000,000 |
ACE, Ltd | Chubb Limited | financial services | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $80,000,000 |
UBS Warburg LLC | UBS | financial services | investor protection violation | 2002 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $80,000,000 |
Bank Julius Baer & Co. Ltd. | Julius Baer Group | financial services | money laundering | 2021 | DOJ_CRIMINAL | $79,000,000 |
UBS Securities LLC | UBS | financial services | consumer protection violation | 2015 | private lawsuit-federal | $78,333,333 |
Swiss Life Holding AG et al. | Swiss Life Group | financial services | tax violations | 2021 | DOJ_TAX | $77,374,337 |
Credit Suisse First Boston LLC | UBS | financial services | investor protection violation | 2003 | MULTI-FIN | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $75,000,000 |
Credit Suisse | UBS | financial services | investor protection violation | 2022 | CFTC | $75,000,000 |
UBS AG | UBS | financial services | investor protection violation | 2022 | CFTC | $75,000,000 |
ABB Ltd | ABB Ltd. | utilities and power generation | Foreign Corrupt Practices Act | 2022 | SEC | $75,000,000 |
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $72,500,000 |
ACE American Insurance Company ET AL. | Chubb Limited | financial services | False Claims Act and related | 2010 | NY-AG | $70,000,000 |
UBS | UBS | financial services | toxic securities abuses | 2016 | NCUA | $69,800,000 |
UBS AG | UBS | financial services | price-fixing or anti-competitive practices | 2018 | MULTI-AG | $68,000,000 |
ABB Inc. | ABB Ltd. | utilities and power generation | benefit plan administrator violation | 2019 | private lawsuit-federal | $55,000,000 |
Credit Suisse Securities (USA) LLC | UBS | financial services | investor protection violation | 2016 | SEC | $54,300,000 |
ABB Middle East & Africa Participations AG | ABB Ltd. | utilities and power generation | price-fixing or anti-competitive practices | 2001 | DOJ_ANTITRUST | $53,000,000 |
Credit Suisse | UBS | financial services | toxic securities abuses | 2016 | NCUA | $50,300,000 |
UBS Securities | UBS | financial services | toxic securities abuses | 2013 | SEC | $50,000,000 |
Aggregate Industries Northeast Region Inc. | Holcim Group | building materials | fraud | 2007 | USAO | $50,000,000 |
Aggregate Industries Northeast Region, Inc. | Holcim Group | building materials | False Claims Act and related | 2007 | MA-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $50,000,000 |
Credit Suisse First Boston Corporation | UBS | financial services | investor protection violation | 2002 | FINRA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $50,000,000 |
Credit Suisse AG | UBS | financial services | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $50,000,000 |
Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $47,498,000 |
Credit Suisse (Hong Kong) Limited | UBS | financial services | Foreign Corrupt Practices Act | 2018 | DOJ_CRIMINAL | $47,029,916 |
UBS | UBS | financial services | wage and hour violation | 2007 | private lawsuit-federal | $45,000,000 |
UBS | UBS | financial services | wage and hour violation | 2007 | private lawsuit-federal | $44,000,000 |
ABB Ltd. | ABB Ltd. | utilities and power generation | Foreign Corrupt Practices Act | 2010 | SEC | $39,300,000 |
Zurich American Insurance Company et al. | Zurich Insurance | financial services | False Claims Act and related | 2010 | NY-AG | $37,500,000 |
InterMune Inc. | Roche | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | FDA | $36,900,000 |